1. Home
  2. ITOS vs FNLC Comparison

ITOS vs FNLC Comparison

Compare ITOS & FNLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • FNLC
  • Stock Information
  • Founded
  • ITOS 2011
  • FNLC 1864
  • Country
  • ITOS United States
  • FNLC United States
  • Employees
  • ITOS N/A
  • FNLC N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • FNLC Major Banks
  • Sector
  • ITOS Health Care
  • FNLC Finance
  • Exchange
  • ITOS Nasdaq
  • FNLC Nasdaq
  • Market Cap
  • ITOS 272.5M
  • FNLC 281.2M
  • IPO Year
  • ITOS 2020
  • FNLC 1999
  • Fundamental
  • Price
  • ITOS $7.48
  • FNLC $25.66
  • Analyst Decision
  • ITOS Strong Buy
  • FNLC
  • Analyst Count
  • ITOS 3
  • FNLC 0
  • Target Price
  • ITOS $21.33
  • FNLC N/A
  • AVG Volume (30 Days)
  • ITOS 268.0K
  • FNLC 26.5K
  • Earning Date
  • ITOS 03-05-2025
  • FNLC 01-22-2025
  • Dividend Yield
  • ITOS N/A
  • FNLC 5.61%
  • EPS Growth
  • ITOS N/A
  • FNLC N/A
  • EPS
  • ITOS N/A
  • FNLC 2.43
  • Revenue
  • ITOS $35,000,000.00
  • FNLC $79,740,000.00
  • Revenue This Year
  • ITOS $271.18
  • FNLC N/A
  • Revenue Next Year
  • ITOS N/A
  • FNLC N/A
  • P/E Ratio
  • ITOS N/A
  • FNLC $10.45
  • Revenue Growth
  • ITOS N/A
  • FNLC 0.35
  • 52 Week Low
  • ITOS $7.09
  • FNLC $21.77
  • 52 Week High
  • ITOS $18.75
  • FNLC $31.05
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 43.24
  • FNLC 41.19
  • Support Level
  • ITOS $7.30
  • FNLC $25.27
  • Resistance Level
  • ITOS $7.91
  • FNLC $26.37
  • Average True Range (ATR)
  • ITOS 0.32
  • FNLC 0.57
  • MACD
  • ITOS -0.02
  • FNLC 0.05
  • Stochastic Oscillator
  • ITOS 17.82
  • FNLC 37.62

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

Share on Social Networks: